RBC
Ronald Blue & Co Portfolio holdings
AUM
$3.1B
1-Year Return
12.82%
This Quarter Return
+0.33%
1 Year Return
+12.82%
3 Year Return
+2.42%
5 Year Return
–
10 Year Return
–
AUM
$1.35B
AUM Growth
+$120M
(+9.8%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
7.68%
Top 10 Holdings %
Top 10 Hldgs %
81.83%
Holding
319
New
37
Increased
134
Reduced
124
Closed
14
Top Buys
| 1 |
Vident International Equity Strategy
VIDI
|
$511M |
| 2 |
iShares Floating Rate Bond ETF
FLOT
|
$26.2M |
| 3 |
iShares TIPS Bond ETF
TIP
|
$19.6M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
$18.4M |
| 5 |
Invesco DB Precious Metals Fund
DBP
|
$12.8M |
Top Sells
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
$285M |
| 2 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
$178M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
$21.6M |
| 4 |
iShares Gold Trust
IAU
|
$4.16M |
| 5 |
iShares MSCI United Kingdom ETF
EWU
|
$3.14M |
Sector Composition
| 1 | Healthcare | 2.47% |
| 2 | Financials | 2.24% |
| 3 | Energy | 2.19% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Staples | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Biogen
BIIB
$20.6B
| $584K | 0.04% |
2,088
+9
| +0.4% | +$2.52K |
|
|
LO
127
DELISTED
LORILLARD INC COM STK
LO
| $584K | 0.04% |
11,539
+106
| +0.9% | +$5.37K |
|
128
Comcast
CMCSA
$125B
| $575K | 0.04% |
22,134
-1,926
| -8% | -$50K |
|
129
Vanguard FTSE Emerging Markets ETF
VWO
$97.2B
| $570K | 0.04% |
+13,840
| New | +$570K |
|
130
GSK
GSK
$81.6B
| $567K | 0.04% |
8,510
+773
| +10% | +$51.5K |
|
131
Vanguard Mid-Cap Value ETF
VOE
$18.8B
| $565K | 0.04% |
7,086
+1,219
| +21% | +$97.2K |
|
|
ARMH
132
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $565K | 0.04% |
10,331
+2,632
| +34% | +$144K |
|
|
RTN
133
DELISTED
Raytheon Company
RTN
| $564K | 0.04% |
6,217
-417
| -6% | -$37.8K |
|
134
Salesforce
CRM
$239B
| $563K | 0.04% |
10,202
-453
| -4% | -$25K |
|
135
BCE
BCE
$23.1B
| $562K | 0.04% |
12,975
+394
| +3% | +$17.1K |
|
136
Starbucks
SBUX
$97.1B
| $557K | 0.04% |
14,218
+2,570
| +22% | +$101K |
|
137
CVS Health
CVS
$93.6B
| $552K | 0.04% |
7,718
+343
| +5% | +$24.5K |
|
138
Colgate-Palmolive
CL
$68.8B
| $546K | 0.04% |
8,368
-5,137
| -38% | -$335K |
|
139
AB InBev
BUD
$118B
| $538K | 0.04% |
5,056
+316
| +7% | +$33.6K |
|
140
Barclays
BCS
$69.1B
| $536K | 0.04% |
31,929
+4,116
| +15% | +$69.1K |
|
141
BHP
BHP
$138B
| $536K | 0.04% |
9,298
-50
| -0.5% | -$2.88K |
|
142
Target
TGT
$42.3B
| $532K | 0.04% |
8,408
+40
| +0.5% | +$2.53K |
|
143
iShares US Treasury Bond ETF
GOVT
$28B
| $531K | 0.04% |
+21,838
| New | +$531K |
|
144
Teva Pharmaceuticals
TEVA
$21.7B
| $528K | 0.04% |
13,185
-1,582
| -11% | -$63.4K |
|
145
Automatic Data Processing
ADP
$120B
| $525K | 0.04% |
7,406
-18
| -0.2% | -$1.28K |
|
146
Estee Lauder
EL
$32.1B
| $516K | 0.04% |
6,849
+33
| +0.5% | +$2.49K |
|
147
MetLife
MET
$52.9B
| $514K | 0.04% |
10,692
+1,478
| +16% | +$71.1K |
|
148
iShares S&P GSCI Commodity-Indexed Trust
GSG
$1.03B
| $502K | 0.04% |
+15,600
| New | +$502K |
|
|
RDS.B
149
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $497K | 0.04% |
6,619
-2,145
| -24% | -$161K |
|
150
Petrobras
PBR
$78.7B
| $491K | 0.04% |
35,603
+13,302
| +60% | +$183K |
|